← SynDRA
MELPHALAN FLUFENAMIDE
SynDRA canonical compound SYN0039835 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | dna alkylating agent |
| Indication | multiple myeloma |
| Disease area | hematologic malignancy |
Mechanisms of action (all sources)
Drug classes
- Alkylating Activity
- Alkylating Drug
ATC classes
Cross-references
Synonyms
- melphalan flufenamide hydrochloride
- pepaxto
- melflufen
- CK 1535
- Melfalan flufenamida
- J-1 (PRODRUG)
- J-1
- J1
- J1 (PRODRUG)
- Melflufen
- PRODRUG J-1
- PRODRUG J1
- Dipeptide-conjugated melphalan prodrug (iv formulation, ovary tumor), Oncopeptides
- Melphalan-flufenamide
- Prodrug J 1
- J 1 (prodrug)
- F70C5K4786
- Ygalo
- melphalanum flufenamidum
- RefChem:810904
- DTXCID50113952
- L-melphalanyl-p-L-fluorophenylalanine Ethyl Ester
- UNII-F70C5K4786
- J 1
- Melphalan flufenamide [USAN:INN]
- WHO 9493
- MFF
- Melphalan flufenamide [INN]
- Pepaxti
- orb1696158
- SCHEMBL18239898
- GTPL11605
- GLXC-25713
- Melphalan flufenamide (USAN/INN)
- MELPHALAN FLUFENAMIDE [USAN]
- AKOS040752993
- MELPHALAN FLUFENAMIDE [WHO-DD]
- BP-44029
Look up MELPHALAN FLUFENAMIDE in the interactive SynDRA portal →